|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-10-31
|
|
pubmed:abstractText |
Ethambutol (EMB) is an important first line drug, however little information on its molecular mechanism of resistance and pathogenicity of resistant isolates is available. Present work was designed to study virulence of the EMB resistant M. tuberculosis strains and the host responses in-vivo on infection of EMB resistant M. tuberculosis using Balb/c mouse model of infection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0255-0857
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
342-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:18974487-Animals,
pubmed-meshheading:18974487-Antitubercular Agents,
pubmed-meshheading:18974487-Chronic Disease,
pubmed-meshheading:18974487-Disease Progression,
pubmed-meshheading:18974487-Drug Resistance, Bacterial,
pubmed-meshheading:18974487-Ethambutol,
pubmed-meshheading:18974487-Female,
pubmed-meshheading:18974487-Lung,
pubmed-meshheading:18974487-Mice,
pubmed-meshheading:18974487-Mice, Inbred BALB C,
pubmed-meshheading:18974487-Mycobacterium tuberculosis,
pubmed-meshheading:18974487-Tuberculosis, Multidrug-Resistant,
pubmed-meshheading:18974487-Tuberculosis, Pulmonary
|
|
pubmed:articleTitle |
Progression of chronic pulmonary tuberculosis in mice intravenously infected with ethambutol resistant Mycobacterium tuberculosis.
|
|
pubmed:affiliation |
Department of Internal Medicine/Infectious Diseases, University of Texas Southwestern Medical Center at Dallas, TX 75390, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
